Results for:(61 found)
Nov 7, 2012 12:15PM on Top StocksBy Minyanville.com

The pharma wins US approval for a new rheumatoid arthritis pill, but Abbott's existing treatment isn't likely to suffer a meaningful hit to sales anytime soon.

Oct 24, 2012 10:46AM on Top StocksBy TheStreet Staff

The company raises sales guidance while reporting better-than-expected Q3 earnings.

Oct 22, 2012 9:18AM on Top StocksBy Jim Cramer

Tech may be spoiling the party, but old standbys like insurers, banks, retail and oil are holding up nicely.

Oct 19, 2012 11:09AM on Top StocksBy MSN Money Partner

SanDisk is upgraded to 'overweight,' while AMD is downgraded to 'market perform.'

Oct 18, 2012 11:43AM on Top StocksBy Stock Traders Daily

Although Abbott has recently gained on positive trial results, Gilead Sciences remains in the forefront of the market.

Oct 18, 2012 11:11AM on Top StocksBy MSN Money Partner

Goldman downgrades Royal Dutch Shell to 'sell' and upgrades ConocoPhillips to 'neutral.'

Oct 17, 2012 5:25PM on Top StocksBy Jim J. Jubak

Both companies want to develop a replacement to the standard year-long injection treatment.

Oct 17, 2012 12:22PM on Top StocksBy MSN Money Partner

Stocks are mixed as news of surging US housing starts partially offsets disappointing earnings from 2 of tech's biggest names.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.

TOP STOCKS

Scary story: the 2013 market looks like 1987

All hail the bull market, which ended the week with a big rally. But it also is starting to look a little like 1987, which suffered an epic blow-out.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More